home / press / releases

Menu
  • Search all tables

releases: https://www.hatch.senate.gov/public/index.cfm/releases?ContentRecord_id=68871271-7276-4fb9-9bae-1bb40df9b5b0

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.hatch.senate.gov/public/index.cfm/releases?ContentRecord_id=68871271-7276-4fb9-9bae-1bb40df9b5b0 Cord Blood and Bone Marrow Bill Co-Sponsors Applaud House Passage, Urge President to Sign 2015-12-17 2015 2015-12 Republican House UT Orrin Hatch H000338 www.hatch.senate.gov     legacy Washington, D.C.Senator Orrin Hatch, member and former chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, along with co-sponsors SenatorsRichard Burr, R-N.C., Franken, D-Minn.,and Jack Reed, D-R.I., issued the following statement after the House passed the Stem Cell Therapeutic and Research Authorization Act of 2015, sending the bill to the Presidents desk for his signature. Reauthorization of thissignificant, life-saving billwill advance the important work of the bone marrow and cord blood programsto promote new discoveries within the fields of cellular therapy and regenerative medicine, said Sen. Hatch.Enacting this billwill also reaffirm the commitment thatCongress made three decades ago to help patients with blood cancers and other life-threatening diseases byincreasing access to life-saving transplants. I am pleased the Senate passed this bill, which builds upon the highly successful National Marrow Donor Program that has been a lifeline for thousands of transplant patients over the last thirty years. I applaud Senator Hatch for his bipartisan leadership on this issue, said Sen. Reed. Bone marrow and cord blood transplants continue to offer effective treatments for a number of diseases and disorders, and passing this legislation marks a critical step forward in expanding access to lifesaving therapies to millions of patients with conditions that can be treated and even cured with bone marrow or cord blood. I am pleased to see that the House took action on this important legislation that can help save and improve the lives of patients who suffer from serious disorders, saidSen. Burr. This critical research is saving lives and bringing these therapies to families across the nation, and we must build on these efforts in order to meet the needs of patients in the future. "Bone marrow and cord blood transplants support tens of thousands of Americans facing devastating diseases like leukemia and lymphoma,said Sen. Franken.This bill will ensure that the National Bone Marrow Donor Program, which is located in Minnesota, remains strong so that children and adults can access these life-saving transplants when they need them most. Im pleased we got this measure finished, and I look forward to the President signing it into law." The Stem Cell Therapeutic and Research Reauthorization Act of 2015 will reauthorize for another five years both the C.W. Bill Young Cell Transplantation Programand the National Cord Blood Inventory (NCBI). The Program and the NCBI provide access to life-saving treatments for serious conditions and disease such as leukemia, lymphoma, immunodeficiency diseases, sickle cell anemia, and certain metabolic diseases. Hatch, Reed, Burr, and Franken cosponsored the bill previously in 2010, and Hatch, Burr, and Reed cosponsored the legislation in2005. The 2005 law created the National Cord Blood Inventory. 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 0.747ms · Data license: MIT · Data source: dwillis/congress-press